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Objective: Liver regeneration is mainly based on cellular
self-renewal including progenitor cells. Efforts have been
made to harness this potential for cell transplantation, but
shortage of hepatocytes and premature differentiated
progenitor cells from extra-hepatic organs are limiting
factors. Histological studies implied that resident cells in
adult liver can proliferate, have bipotential character and
may be a suitable source for cell transplantation.
Methods: Particular cell populations were isolated after
adequate tissue dissociation. Single cell suspensions were
purified by Thy-1 positivity selection, characterised in vitro
and transplanted in immunodeficient Pfp/Rag2 mice.
Results: Thy-1+ cells that are mainly found in the portal
tract and the surrounding parenchyma, were isolated from
surgical liver tissue with high yields from specimens with
histological signs of regeneration. Thy-1+ cell populations
were positive for progenitor (CD34, c-kit, CK14, M2PK,
OV6), biliary (CK19) and hepatic (HepPar1) markers
revealing their progenitor as well as hepatic and biliary
nature. The potential of Thy-1+ cells for differentiation in
vitro was demonstrated by increased mRNA and protein
expression for hepatic (CK18, HepPar1) and biliary (CK7)
markers during culture while progenitor markers CK14,
chromogranin A and nestin were reduced. After
transplantation of Thy-1+ cells into livers of immunodefi-
cient mice, engraftment was predominantly seen in the
periportal portion of the liver lobule. Analysis of in situ
material revealed that transplanted cells express human
hepatic markers HepPar1 and albumin, indicating func-
tional engraftment.
Conclusion: Bipotential progenitor cells from human
adult livers can be isolated using Thy-1 and might be a
potential candidate for cell treatment in liver diseases.
In response to liver injury, hepatic cells, especially
hepatocytes, can rapidly proliferate to repair liver
damage.1 After hepatectomy hepatocytes are able
to undergo numerous cell divisions maintaining
their fully differentiated state to compensate for
hepatocyte loss, whereas undifferentiated liver
progenitor cells play only a minor role in this
process. Interestingly, under conditions such as
some chronic liver diseases and after acute necrosis
these hepatocyte progenitors play an important
role, in particular when growth response of mature
hepatocytes is impaired.1 2
Mechanisms leading to progenitor cell activation
have been studied in detail using rodent models of
hepatocarcinogenesis and liver regeneration after
toxic injury.3 4 Under these conditions increasing
numbers of small cells (,10 mm) were observed
having a large nuclear-to-cytoplasm ratio with an
oval-shaped nucleus (oval cells). They express
markers of both hepatocyte lineages and the biliary
epithelium that includes bile ducts as well as the
canal of Hering.5 6 Although histochemical studies
suggest that epithelial cells residing within the
canal of Hering might be resident liver stem cells,
the precise origin remains ambiguous.6 In humans
these cells are termed progenitor cells/ductular
reaction7 and are activated in different diseases such
as chronic viral hepatitis, alcoholic liver disease, non-
alcoholic fatty liver disease and cirrhosis.4 8 They are
observed in the portal region of the hepatic lobule9–11
and, furthermore, their numbers increase in direct
proportion to disease severity.12
Hepatic progenitor cells have also been shown to
express haematopoietic stem cell (HSC) markers
CD34, c-kit (CD117)13 and Thy-1 (CD90).14
Accordingly, it was hypothesised that these cells
are haematopoietic stem cells transdifferentiated
into the hepatic lineage.15 However, recent reports
have demonstrated that cell fusion rather than
transdifferentiation is involved in this process.
Also, it was shown that rodent oval cells do not
originate from bone marrow,16 but bone-marrow-
derived stem cells may contribute to liver regenera-
tion in an as yet unknown mechanism.17
Isolation procedures for hepatic progenitor cells
were established for rodents and in vitro studies have
shown that these cells are capable of differentiating
into hepatocytes and bile duct cells under appro-
priate conditions.18 Isolation of liver progenitor cells
from human material has proven more difficult.
Indeed, only a few reports describe an isolation of
progenitor cells from fetal livers. These cells
expressed various lineage specific antigens including
biliary and hepatocellular markers.19 In adult human
liver, progenitor cells have been identified by CD34
and c-kit immunoreactivity,13 but the so-called side-
population was also found.20 Recently, it was
documented that Thy-1 (CD90) is expressed in
human hepatoblastoma.21 This surface antigen has
also been useful for successfully isolating progenitor
cells from human fetal liver.14 However, to our
knowledge, there have been no attempts so far to use
this marker for the separation of progenitor cell
populations from adult human liver tissues. Since
such cell populations may become central determi-
nants for future treatments of liver diseases requiring
clinically relevant liver regeneration, we aimed to
identify and isolate Thy-1+ cells from adult liver
tissue for cell transplantation purposes. We analysed
the phenotypic characteristics of Thy-1+ human
progenitor cells after isolation, studied their differ-
entiation potential in vitro and monitored their
repopulation capacity in vivo in a mouse model of
liver regeneration.
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MATERIALS AND METHODS
Reagents and material
Antibodies for this study are summarised in table 1. Mouse anti-
rabbit IgG, rabbit anti-mouse IgG, and mouse APAAP were
obtained from Dako (Hamburg, Germany). Texas red-conjugated
donkey anti-rabbit antibody and fluorescein isothiocyanate
(FITC)-conjugated donkey anti-mouse antibody were obtained
from Jackson Immunoresearch (Newmarket, UK). RNase A was
purchased from Qiagen (Hilden, Germany), DNase I and fast red
substrate from Roche Diagnostics (Mannheim, Germany). All
further chemicals were purchased from Sigma (Taufkirchen,
Germany) or Merck (Darmstadt, Germany).
Tissue samples from human liver resections were obtained
from patients undergoing partial hepatectomy. Experimental
procedures were performed according to the guidelines of the
charitable state-controlled foundation HTCR (Human Tissue
and Cell Research), with the informed patient’s consent
approved by the local ethics committee of the University of
Regensburg.22 A total of 39 liver specimens were categorised into
regenerating (n = 20; age 53.7 (SD 15.6) years; male 13, female
7) and non-regenerating (n = 19; age 61.7 (SD 12.2) years; male
15, female 4) tissue according to a histological and clinical
examination by specialist. Non-regenerating liver was assigned
to patients with metastatic liver tumours of colorectal cancer
and regenerating liver to patients with disease as following:
fibrosis/cirrhosis (n = 4; age 53.0 (SD 9.3) years; male 4),
fibrosis/non-alcoholic steatohepatitis (NASH) (n = 4; age 58.0
(SD 11.2) years; male 2, female 2), fibrosis/alcoholic steatohe-
patitis (ASH) (n = 1; age 23; female), cirrhosis/ASH (n = 2; age
64.5 (SD 4.5) years; male 2), steatosis (n = 7; age 53.7 (SD
19.7) years; male 3, female 4), ASH (n = 1; age 49 years; male),
NASH (n = 1; age 52 years; male).
Isolation of Thy-1 positive cells from human liver tissue
Isolation of non-parenchymal cells
Liver tissue was digested using a modified two-step egtazic acid
(EGTA)/collagenase perfusion procedure23 to isolate human
hepatocytes. Non-parenchymal cells (NPCs) were obtained
from the remaining liver tissue based on a protocol described
recently.24 Briefly, up to 50 g of tissue was minced and
incubated for up to 150 min under vigorous shaking at 37uC
in 50 ml isolation buffer (154 mmol/l NaCl, 5.6 mmol/l KCl,
5 mmol/l glucose, 25 mmol/l NaHCO3, 20 mmol/l HEPES,
pH 7.4) supplemented with 0.5 mg/ml collagenase type IV,
0.5 mg/ml pronase, 40 mg/ml DNase I, 5 mmol/l CaCl2 and
1 mmol/l MgCl2. Every 30 min undigested tissue was separated,
minced and incubated again. The resulting suspension was
filtered (meshes with 210 mm and 170 mm pore sizes) and washed
three times in phosphate-buffered saline (PBS) containing
2 mmol/l ethylenediaminetetraacetic acid (EDTA). Furthermore,
the cell suspension was purified using a 70% Percoll solution
(800 g, 30 min, 18uC). After washing with PBS/EDTA, the NPCs
were suspended in MACS buffer (PBS containing 2 mmol/l
EDTA, 5 g/l bovine serum albumin (BSA)) and stored for up to
20 h at 4uC. Size profile of cell fractions was monitored for quality
assessment of the dissociation procedure using a cell counter
system (Casy Scha¨rfe System, Reutlingen, Germany). NPC
fractions were isolated with an average yield of 2.7 (SD 2.6)6106
viable cells per g wet tissue (n = 39).
Purification of Thy-1 positive cells
Thy-1+ cells were isolated from NPCs using the immuno-
magnetic activated cell sorting (MACS) technique (Miltenyi
Biotech, Bergisch Gladbach, Germany) according to the instruc-
tion manual. Briefly, cells were filtered (40 mm filter, BD
Biosciences Europe, Erembodegem, Belgium) and 56107 cells
were incubated with 100 ml of a mouse anti-CD90 (Thy-1)
monoclonal antibody (mAb) for 30 min at 4uC. After twofold
washing with MACS buffer, cells were incubated with 100 ml of
goat anti-mouse microbeads for 15 min at 4uC followed by two
additional washing steps. Labelled cell suspensions were
transferred onto MACS LS columns and washed three times
while being located in the magnetic field. Thy-1+ cells were
eluted with 5 ml MACS buffer following removal from the
magnet. Cell number and viability were determined by the
trypan blue exclusion technique.
Characterisation by flow cytometry
Cells were suspended in PBS, incubated with fluorescence-
labelled mAb for 30 min at 4uC, washed with PBS and analysed
following addition of propidium iodide (PI) (1 mg/ml PI per
Table 1 Antibodies used for immunohistochemistry (IHC) and flow cytometry
Antibody Species Manufacturer Catalogue number Dilution Application
Albumin Rabbit polyclonal IgG Abcam ab2406 1:1000 IHC
CD3-FITC Mouse monoclonal IgG2a/MEM-57 AbD Serotec MCA2184F 5 ml/106 cells Flow cytometry
CD14-FITC Mouse monoclonal IgG1/MEM-18 AbD Serotec MCA2185F 5 ml/106 cells Flow cytometry
CD34 Mouse monoclonal IgG1/Qbend10 Dako M7165 1:100 IHC
CD34-FITC Mouse monoclonal IgG1/8G12 BD 345801 20 ml/106 cells Flow cytometry
CD45-FITC Mouse monoclonal IgG1/2D1 BD 345808 10 ml/106 cells Flow cytometry
Thy-1 (CD90) Mouse monoclonal IgG1/5E10 BD Pharmingen 555593 1:250 IHC, Flow cytometry
CD90-PE Mouse monoclonal IgG1/5E10 BD Pharmingen 555596 5 ml/106 cells Flow cytometry
c-kit (CD117) Mouse monoclonal IgG2a/K45 NeoMarkers MS-289 1:100 IHC
CD117-PE Mouse monoclonal IgG1/104D2 Southern Biotech 9815-09C 10 ml/106 cells Flow cytometry
CK7 Mouse monoclonal IgG Dako M7018 1:100 IHC
CK14 Rabbit polyclonal IgG Zytomed RP113 1:50 IHC
CK18 Mouse monoclonal IgG1/CK2 Chemicon MAB3404 1:100 IHC
CK19 Mouse monoclonal IgG1/RCK108 Dako M0888 1:100 IHC
HepPar1 Mouse monoclonal IgG1/OCH1E5 Dako M7158 1:50 IHC
M2-PK Mouse monoclonal IgG1/DF4 ScheBo Biotech S-1 1:10 IHC
OV6 Mouse Gift from S. Sell* 1:100 IHC
Manufacturers: Abcam, Cambridge, UK; AbD Serotec, Du¨sseldorf, Germany; BD, Heidelberg, Germany; BD Pharmingen, Heidelberg, Germany; Chemicon, Schwalbach, Germany;
NeoMarkers, Dreieich, Germany; ScheBo Biotech, Giessen, Germany; Southern Biotech, Birmingham, Alabama, USA; Zytomed, Berlin, Germany.
*We are grateful to Dr S. Sell (Department of Pathology and Laboratory Medicine, Albany, NY, USA) for the kind gift of OV6 antibody.
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1 mg/ml RNase A) on a FACSCalibur flow cytometer (BD,
Heidelberg, Germany) using appropriate regions of interest and/
or quadrant statistics in the compensated fluorescence dot plot
diagrams. PI positive, membrane defect cells were excluded.
Details concerning the antibodies are given in table 1.
Immunohistochemical staining
Cryosections (6 mm) from snap frozen tissues were fixed in ice-
cold acetone (10 min). For cytospots freshly isolated cells were
suspended in PBS, centrifuged (56104 cells) onto glass slides
(SuperFrost Plus; Merck) and fixed in acetone. Cultured cells
were fixed using 4% paraformaldehyde for 20 min.
Alkaline phosphatase anti-alkaline phosphatase (APAAP) staining
Blocking of slides was performed with 3% fetal calf serum (FCS)
in PBS followed by incubation with primary antibodies for
30 min and a washing step with PBS. For CK14 staining,
additional incubation with mouse anti-rabbit immunoglobulins
for 30 min was performed, followed by incubation with rabbit
anti-mouse immunoglobulins for 30 min. After incubation with
mouse APAAP (1:100 in PBS/1% FCS) for 30 min immuno-
signals were developed with fast red substrate (20 min) and
counterstained with haematoxylin Quick Stain.
Immunofluorescence staining
After blocking (3% dried milk, 0.1% Triton-X100, PBS) cells
were incubated with primary antibodies for 30 min, washed
with PBS and incubated with the secondary fluorescence-
conjugated antibodies. For co-localisation, steps were repeated
with a second set of antibodies. Nuclei were counterstained
with 5 mg/ml Hoechst 33258 in PBS.
Determination of mRNA expression by reverse transcription-
polymerase chain reaction
Total RNA was extracted using the RNeasy Mini Kit (Qiagen).
First strand cDNA was synthesised using 0.1 mg of total RNA
and the avian myeloblastosis virus (AMV)-reverse transcription
reaction (Promega, Mannheim, Germany) using 15 U AMV
reverse transcriptase in a prolonged incubation time of 60 min.
The polymerase chain reaction (PCR) was performed according
to the manufacturer’s instructions (Invitrogen, Karlsruhe,
Germany) using primers as listed in table 2. After an initial
denaturation step of 3 min at 94uC, amplification was
performed for 35 cycles at 94uC for 45 s, 30 s at the optimal
annealing temperature and 72uC for 30 s. The PCR was
terminated by a final elongation step at 72uC for 10 min.
Amplified products were transferred on 1.5% agarose gels for
electrophoresis followed by ethidium bromide staining.
Cell culture
Freshly isolated Thy-1+ cells were resuspended in adhering
medium (William’s E medium, 5% FCS, 10 mmol/l nicotina-
mide, 20 mmol/l HEPES, 17 mmol/l NaHCO3, 550 mg/l
sodium pyruvate, 0.2 mmol/l ascorbic acid 2-phosphate,
14 mmol/l glucose, 1027 mol/l dexamethasone, 6.25 mg/ml
insulin, 6.25 mg/ml transferrin, 6.25 ng/ml sodium selenite,
1.25 mg/ml BSA and 5.35 mg/ml linoleic acid, 100 U/ml
penicillin, 100 mg/ml streptomycin) and plated onto collagen
coated dishes (BD Biosciences Europe) at a density of
56104/cm2. After 3–5 days the medium was replaced with
culture medium (adhering medium without FCS, 20 ng/ml
epidermal growth factor (EGF)). The medium was changed once
a week. Viability and cell growth during the culture period were
monitored by cell morphology.
Transplantation of hepatic progenitor cells
All animal housing and experimentation procedures were in
accordance with German legislation on animal protection (latest
version). Pfp/Rag22/2 mice (malfunction of NK cell, T and B cell
depletion) were obtained at 8 months of age from Taconic (Lille
Skensved, Denmark). The cellular transplantation model was
performed as described recently.25 26 Briefly, recipient liver
regeneration was inhibited by treating the mice with mono-
crotalin (30 mg/kg body weight; intraperitoneally) 6 and 4 weeks
prior to transplantation. After partial hepatectomy, 16106 human
Thy-1 positive liver cells were administered by intrasplenic
injection. Livers were removed after 7 weeks and fixed in 4%
formaldehyde and paraffin embedded for further analysis.
Table 2 Primer sequences, annealing temperature and expected size of amplified products for polymerase








AFP NM_001134 fw TGCAGCCAAAGTGAAGAGGGAAGA 55uC 216
rv ATAGCGAGCAGCCCAAAGAAGAA
Albumin NM_000477 fw GCTGCCATGGAGATCTGCTTGA 55uC 174
rv GCAAGTCAGCAGGCATCTCATC
ChromA NM_001275 fw CGCGCCTTGTCTCCTACTC 50uC 254
rv AGGAAAGAGCCCAGAACAGAT
CK7 NM_005556 fw TCCGCGAGGTCACCATTAAC 55uC 218
rv GCTGCTCTTGGCCGACTTCT
CK14 NM_000526 fw GGGCGGCCTGTCTGTCTC 60uC 237
rv AGGCGGTCATTGAGGTTCTG
CK18 NM_000224 fw CCCGCTACGCCCTACAGA 53uC 248
rv GCGGGTGGTGGTCTTTTG
CK19 NM_002276 fw CGAGCAGAACCGGAAGGATG 53uC 318
rv AGCCGCTGGTACTCCTGATTC
Nestin NM_006617 fw GGGGGCAATGAATCCTCTAG 50uC 295
rv CACCGTATCTTCCCACCTCTG
b-Actin NM_001101 fw GCCGGGACCTGACTGACTAC 53uC 327
rv TGCGGATGTCCACGTCAC
AFP, alpha-fetoprotein; fw, forward; rv, reverse.
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RESULTS
Expression of progenitor cell marker in human liver sections
Expression analysis of markers described for liver progenitors
were performed in cryo-sections of adult liver tissue from a
patient with fat liver disease. Immunoreactivity for CD34 was
found in endothelial cells lining the vascular structures of the
portal tract and sparely on cells in the adjacent parenchyma
(fig 1A), whereas c-kit expression was barely detected (fig 1C).
Thy-1 expression was found in the portal tract area and in
scattered cells in the surrounding parenchyma (fig 1B).
Expression of the oval cell marker OV6 was detected on
epithelial cells adjacent to the portal tract, but primarily on bile
duct cells (fig 1D). Specific immunostaining of CK19 for biliary
epithelial cells (fig 1E), CK18 for bile duct epithelium and
parenchymal hepatocytes (fig 1F) is also demonstrated.
Cells of adult human non-parenchymal liver cell fractions
express stem cell markers
Fractions of small liver cells separated from hepatocytes were
isolated from discarded surgical adult human liver tissue after
performing a multi-step isolation process (fig 2A–B).
Immunocytochemical analysis of small liver cell fractions
revealed a high percentage of non-parenchymal cells (Kupffer,
stellate and endothelial cells; data not shown) and are therefore
termed the non-parenchymal cell (NPC) fraction. NPC fractions
were investigated by flow cytometry for expression of surface
markers, which have been detected on liver progenitor cells by
immunohistochemistry. Cells were found positive for CD34
(6% (SD 4%), n = 18), CD117 (8% (SD 7%), n = 18) and CD90
(9% (SD 6%), n = 22). Additionally, double immunostaining
revealed, that 2% (SD 2%) (n = 11) of NPC fractions were
CD34+/CD90+, 2% (SD 2%) (n = 9) were CD34+/CD117+ and
3% (SD 1%) (n = 5) were CD90+/CD117+.
Thy-1 positive cells express markers of liver progenitor cells
Thy-1 (CD90), the most abundant progenitor marker on NPC
fractions, was selected as a marker for immuno-magnetic
activated cell sorting (MACS). Subsequently, fluorescence-
activated cell sorting (FACS) analysis was performed determin-
ing the quantity and characteristics of Thy-1 isolated cells.
MACS sorted cells were highly positive for Thy-1 (83% (SD
7%), n = 6) and co-expressed CD34 (24% (SD 9%), n = 5) and
hardly CD117 (1.8% (SD 0.7%), n = 5) (fig 2C–E). Additionally,
we found expression of CD45 (35% (SD 9%), n = 5), CD14 (20%
(SD 7%), n = 5) and CD3 (29% (SD 9%), n = 5) on some Thy-1+
cells. The overall outcome of viable Thy-1+ cells after MACS
isolation was 1.4 (SD 0.9)6104 per 106 NPCs (n = 39).
Furthermore, performing a correlation study we found a
significant higher rate of Thy-1+ cells in tissues, in which
regenerative events; for example, slight histological signs of
hepatitis, fibrosis, or cirrhosis, were described (1.8% (SD 1.0%)
of NPCs, n = 20) than in non-regenerating tissue (1.2% (SD
0.57%) of NPCs, n = 19) (fig 2G). The rates of Thy-1+ cells were
not correlated with expression of CD45, CD14 and CD3 (data
Figure 1 Immunohistochemical staining of human liver sections (from a patient with alcoholic fatty liver disease) for markers of progenitor, hepatic
and biliary cells. (A) Immunostaining for CD34 was found on endothelial cells lining the vascular structures of the portal tract (arrow head) and sparely
on some cells in adjacent liver (arrow). (B) Positive staining for Thy-1+ was found in the portal tract area and for some parenchymal cells (arrow head).
(C) Only spare positive immunostaining could be detected for c-kit expressing cells. (D) OV6+ cells were mainly detected in parenchyma surrounding the
portal area (arrow) and in bile duct (arrow head). (E) Bile duct cells were immunoreactive for CK19 (arrow head), whereas (F) CK18 was found on
hepatocytes and bile duct cells. (A–F: original magnification, 6200).
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not shown). A more detailed analysis with type of disease,
tissue damage and patient related data did not show any
correlation to the rate of Thy-1+ cells (data not shown).
Expression of progenitor and hepatic cell markers were
determined on freshly isolated Thy-1+ cells by immunostaining
(fig 3). About 60% of the Thy-1+-sorted cells demonstrated
positivity for liver progenitor markers CK14, M2PK, OV6 and
biliary/progenitor marker CK19 (fig 3A). Double immunofluor-
escence staining of Thy-1+ cells revealed co-localisation of CK14
with CD117, CD34 (liver progenitor and HSC), CK19 (bile
duct/progenitor cell), HepPar1 (hepatocyte) and OV6 (fig 3B).
mRNA analyses of the Thy-1+ cell population from 27 donors
confirmed the expression of CK14. Also, we detected two
additional progenitor genes expressed in Thy-1+ cells of all
donors, chromogranin A (pancreatic) and nestin (neural) (fig 4).
Positive gene expression was also found for hepatocyte markers
CK18 and albumin (10 of 27), as well as biliary marker CK19,
but not for CK7. alpha-fetoprotein (AFP) was not detected in
any of the cell preparations (fig 4).
Thy-1 positive liver cells in culture show differentiation towards
hepatocytes and bile duct cells
Thy-1+ cells were seeded on collagen-coated culture dishes and
maintained in culture under conditions described for hepatocyte
growth.27 Efficiency of plating was sufficient and after 10–
14 days cells started to grow into colonies (fig 5A–C). At day 28
of culture an almost complete monolayer was formed (fig 5D).
Furthermore, mRNA analyses by reverse transcription poly-
merase chain reaction (RT-PCR) were performed throughout
culturing and differences in gene expression were observed
depending on the culture period (fig 5G). The hepatic marker
CK18 strongly increased from day 14 to 28, whereas albumin
could not be detected. Furthermore, CK19 expression was
almost unchanged up to day 28, while the gene expression of
the bile duct marker CK7 was clearly enhanced. In contrast, a
reduction of the progenitor markers CK14, chromogranin A and
nestin was observed as a function of time in culture. AFP was
not expressed either in fresh or in cultured cells. In addition,
Thy-1+ cells cultured for 14 days were stained with antibodies
Figure 2 Isolation and characterisation of progenitor cell fractions from human liver tissue. Size profiles of Percoll purified liver cell fractions show
(A) Hepatocytes (diameter, 20 (SD 5) mm) separated from (B) smaller liver cells (diameter, 8–13 mm). Fractions of dead cells are indicated by an
asterisk and cell debris is found at particle sizes of below 6 mm. The Thy-1 positive cells isolated by using immuno-magnetic activated cell sorting
(MACS) were further characterised by fluorescence-activated cell sorting (FACS) analysis for their expression of (C) CD90, (D) CD34, and (E) CD117.
Data are from one analysis representative of five independent experiments. Unfilled curve: before MACS isolation; filled curve: after MACS isolation.
(F) Thy-1+ cells were further purified by MACS and their outcome was correlated to the underlying disease. The tissues were categorised to
regenerating (n = 20) and non-regenerating (n = 19) liver from patients with cirrhosis, fibrosis, alcoholic liver disease (ALD), non-alcoholic fatty liver
disease (NAFLD) and colorectal liver metastases, respectively. *p,0.05, differs from non-regenerating liver tissue. FITC, fluorescein isothiocyanate;
NPCs, non-parenchymal cells; PE, phycoerythrin.
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Figure 3 Immunocytochemical staining
of Thy-1+ cells for liver progenitor and
hepatic markers. (A) Cytospots of Thy-1-
sorted cells were stained for liver
progenitor makers such as CK14, M2PK,
OV6 and the biliary marker CK19 (original
magnification, 6200). (B) Double
immunofluorescence staining of Thy-1-
sorted cells was performed to detect co-
localisation of liver progenitor marker
CK14 with markers specific for
haematopoietic stem cells (HSCs) and
liver progenitors (CD177, CD34), bile duct
cells (CK19), hepatic cells (HepPar1) and
oval cells (OV6) (original magnification,
6400).
Hepatology
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against HepPar1 and CK7 and demonstrated expression of
hepatocyte and bile duct specific proteins, respectively (fig 5E,F).
Transplanted Thy-1 positive cells demonstrate engraftment in
mouse livers
Integration of transplanted Thy-1+ cells was studied using a
mouse transplantation model, which impedes proliferation of
residual hepatocytes after partial hepatectomy and therefore
supply transplanted Thy-1+ cells with a growth advantage over
host hepatocytes.25 Seven weeks after transplantation human
hepatic cells were detected in the mouse liver background by
staining with HepPar1 (human hepatocyte specific antigen)
antibody (fig 6A–C), which showed no relevant cross-reactivity
for murine antigens. In cryosections of the respective materials,
human albumin, a marker of functional activity and hepatocyte
differentiation was also detected (fig 6D,E). HepPar1 and
albumin positive cells were localised in the periportal region,
demonstrating a predominant periportal engraftment of trans-
planted Thy-1+ liver cells. After transplantation into mouse liver
Thy-1+ sorted cells featured a typical human hepatocytic
phenotype indicating integration of the transplanted cells
within the mouse liver.
DISCUSSION
The objective of this paper was to determine whether Thy-1
positive cells (1) were found in and could be isolated from
human liver tissue; (2) demonstrate multiple lineage markers
common with a progenitor phenotype; and (3) have the
potential for cellular treatment in liver regeneration. The data
presented show that adult human liver harbours Thy-1
positive cells which express hepatocellular and biliary markers
representing their bipotential character. These cells have a
repopulation capacity after transplantation and therefore
resemble a liver progenitor cell type.
Because of their anatomical homology, both adult and fetal
livers have been considered to harbour progenitor cells in the
ductules/canals of Hering at the interface between the
parenchymal and the portal tract mesenchyme.6 28 These
progenitor cells were defined in humans based on immunohis-
tochemical studies as larger than 6 mm and less than 40 mm in
diameter,7 which agrees with the isolated progenitor cell
fraction (10 (SD 3) mm) in this study and, furthermore, might
correspond in size to progenitor cells isolated from rat (8–
10 mm)29 and mouse (7–15 mm).30 The isolated small liver cells
partly showed co-expression of CD34, c-kit and Thy-1, which
are markers of the haematopoietic compartment and were
described as being present in human13 14 and rodent liver.31
Furthermore, we found some Thy-1+ cells positive for CD45
which was also reported earlier by others using human fetal14
and murine liver.30 CD45 positivity, in general, indicates a
haematopoietic lineage,32 but recent reports clearly show that
hepatic side-population cells, a further characteristic of pro-
genitor cells,33 both CD45 positive and negative, can differenti-
ate into hepatic cells expressing HepPar1 and albumin20 and
upon transplantation into a mouse model, can contribute to
liver regeneration.34 Therefore, the CD45 surface antigen
expression status is suggested as not important in terms of
the hepatic differentiation potential. Additionally, by using
immunohistochemistry we found Thy-1 and CD34 expressed
on endothelial cells lining the vascular structures of the portal
tract which might correspond to a stem cell niche of the
mesenchymal compartment giving rise to mesodermal and
epithelial tissue as suggested earlier.14
Thy1+ cells in human liver feature bipotential progenitor cells
with hepatic characteristics
Progenitor cells are often recognised by expression of organ
specific fetal proteins, which demonstrate their early status in
development. Isolated human Thy-1+ cells showed specific
expression of M2PK, the fetal M2 isoform of pyruvate kinase
(M2PK), which is considered as a marker for liver progenitor
cells, not expressed in adult hepatocytes and ductal cells.12
Furthermore, we did not find mRNA expression of AFP, a
serum glycoprotein produced by hepatoblasts during the fetal
development, a defining feature of progenitor cells in many
rodent models of injury7 and in human fetal livers.14 On the
other hand, it was reported that AFP in progenitor cells from
adult human liver was only occasionally observed7 and it was
recently shown that during progenitor cell activation in a rat
model, the non-ductular progenitor cells expressing nestin and
Thy-1 were negative for AFP.35
A characteristic of liver progenitor cells is the co-expression of
different cell specific proteins enabling a differentiation into
hepatic and/or biliary epithelial cells. We could demonstrate
that the biliary marker CK19 as well as the oval cell marker
OV636 were not only detected on bile duct cells by immuno-
histology, but also were present on Thy-1+ cells indicating these
markers as liver progenitor markers as suggested before for
CK197 and OV6.37 The bipotential nature of Thy-1+ cells is
shown by expression of CK19 and HepPar1, antigens identified
on liver progenitor cells during early stages of gestation.38
Enhanced or reduced expression of either markers commits to
biliary or hepatocyte epithelial cell lineages. HepPar1 antibodies
recognise the mitochondrial fraction of human hepatocytes and
do not label haematopoietic or non-parenchymal cells.39 Further
Figure 4 Semiquantitative reverse transcription-polymerase chain
reaction (RT-PCR) analysis of mRNAs from Thy-1 sorted liver cells of
seven representative different donors. Gene expression of hepatic (alpha-
fetoprotein (AFP), albumin, CK18), bile duct (CK19, CK7), liver progenitor
(CK14), pancreatic (chromogranin A) and neural (nestin) cell markers
were investigated. The following samples were used for controls: AFP,
CK14, b-actin (hepatocellular carcinoma), albumin, CK18 (human
hepatocytes), CK19, CK7 (cholangiocarcinoma), chrom A (Panc-1 cell
line) and nestin (glioblastoma).
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evidence suggesting Thy-1+ cells as bipotential liver progenitors
comes from our RT-PCR analysis which showed expression of
the biliary lineage marker CK19 as well as hepatocytic lineage
marker CK18 and partly albumin. Additionally, Thy-1+ cells
revealed expression of the neuroendocrine marker chromogranin
A28 and neural progenitor cell marker nestin,40 both suggested as
marker proteins of bipotential liver progenitors. Expression of
these markers has also been seen on differentiated cells from the
haematopoietic lineage and therefore may indicate a relation-
ship between the haematopoietic system and liver cell lineage
either originating from or both having a common ancestor
during the fetal liver development when haematopoietic cells
colonise the liver.16 Furthermore, CK14 has been described as a
marker of bipotential liver progenitors and was detected in
human regenerating livers after massive necrosis.38 41 Although it
was reported that OV6 antibodies in rat liver recognise an
epitope common to both CK19 and CK14 present on rodent
progenitor cells,42 in human tissue controversial data about
specificity are reported describing expression patterns of OV6
and CK19 as non-coincidental43 and of OV6 and CK14/CK19 as
similar.41 We found that Thy-1+ cells demonstrate double
immuno-positivity for CK14 and CK19 as well as CK14 and
OV6 suggesting co-expression of these markers on Thy-1+ cells.
Co-expression of CK14, CK19 and positivity for OV6 of Thy-1+
cells might indicate a similarity of human progenitor cells to the
progenitor cell development in rodents as it was postulated in
human fetal liver.14 Our findings of Thy-1+ cells isolated from
adult human liver tissue and expressing a variety of progenitor,
biliary and hepatocytic markers might correspond to a more
accepted understanding that human liver progenitor cells do not
represent a single, defined cell type but rather a range of cells of
intermediate hepatobiliary phenotype.7
Thy-1+ progenitor cells may differentiate into hepatic cells and
repopulate a host liver
Activation and expansion of liver progenitor cells is dependent
on a specific microenvironment involving multiple growth
modulators, which are likely to be mimicked in a variety of in
vitro models.44 Using a protocol for hepatocyte expansion27 we
could induce proliferation of Thy-1+ cells in vitro, which was
paralleled by differentiation into hepatocytic but also biliary
lineage without favouring one of each other. During culture
expression of progenitor markers (chromogranin A, nestin,
CK14) decreased and both hepatocytic and biliary markers
increased, which may resemble a process of liver development.
Furthermore, it is suggested that progenitor cells losing CK14
Figure 5 Culture of Thy-1 positive liver cells and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis of mRNAs. Cells
plated on collagen-coated dishes after (A) day 1 showing singular cells, (B) day 10 and (C) day 15 forming small colonies. After cultivation until day 28
(D), a complete monolayer was formed, containing cells with mature hepatic morphology. Immunocytochemical staining of cultured Thy-1 positive cells
at day 14 was performed for (E) bile duct (CK7) and (F) hepatic (HepPar1) cell markers. (Original magnification,6200; seven independent experiments
in triplicates.) (G) Gene expression of hepatic (alpha-fetoprotein (AFP), albumin, CK18), bile duct (CK19, CK7), liver progenitor (CK14), pancreatic
(chromogranin A) and neural (nestin) mRNA markers were studied during culture of Thy-1-sorted liver cells. Control samples were used as indicated in
fig 4 (b-actin as positive control; four independent experiments in triplicates). DAPI, 49,6-diamidine-29-phenylindole.
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expression become committed to either hepatocyte or biliary
epithelial cell lineages.38 Interestingly, CD34+ and c-kit+ cells
isolated from adult human liver were shown to differentiate
only into biliary epithelial cell lineage based on a biliary cell
growth media,13 which did have an impact on the differentiation
of Thy-1+ cells in this study (data not shown).
To further assess the participation of transplanted Thy-1+
cells in liver regeneration a mouse model for cell transplantation
after partial hepatectomy was used.25 26 Interestingly, freshly
isolated Thy-1+ cells showed a weak or negative albumin
expression. After transplantation the cells showed clear albumin
expression even though it was not detectable during culture.
Studies for in vitro differentiation of progenitor cells may
not14 19 45 or do lead to expression of functional genes such as
albumin19 45 depending on specific culture conditions. After
transplantation and the under influence of a variety of factors in
vivo, differentiation of progenitors is seen from low or none to
albumin expressing cells even in a xenogenic model.19 45
However the repopulation efficiency was quite low (about
3%) to replace cells and reverse a pathological condition,46 but
was within the range of published data for liver cell engraftment
in xenogenic models. One reason might be murine liver failing
the proper microenvironment for the human cells and therefore
no cell cluster formation was seen.
Human bipotential liver progenitor cells would be an
invaluable therapeutic tool to induce liver regeneration or to
support liver function by cell transplantation, because of the
increasing disparity between the increase in end stage liver
diseases and the shortage of suitable donor organs. This study
might suggest a strategy of isolating progenitor cells from
resected, slightly diseased, liver tissue followed by an autogenic
re-transplantation of, for example, genetically altered cells to
enrich the regenerative potential. Future research on human
adult liver progenitor cells should address the question of
separation of different subpopulations, their specific capabilities
for expansion in vitro and their applicability for transplantation.
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